TCT 484: Twelve Week Safety and Efficacy of a Novel Extravascular Bi-lateral Renal Denervation Device in a Porcine Model at Nominal Dose

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Grant Support/Research Contract - Boston Scientific Corporation; Metavention; Venturemed Group; Medinol; Global Vascular; Sahajanand Medical Technologies Ltd.; Johnson & Johnson; DeepQure Inc.